Given the overall abundance of CD3+CD56+ T cells in the liver and the frequent occurrence of FOXP3 expression (up to 65%) in the tumor tissue, the FOXP3+CD3+CD56+ cells could play a substantial role in the immunosuppressive network in HCC, at least for some patients. Here, NCAM1 is linked to hepatocellular carcinoma.